| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Long-Term Potentiation | 54 | 2024 | 162 | 13.730 |
Why?
|
| Nicotine | 22 | 2020 | 140 | 7.020 |
Why?
|
| Hypothyroidism | 19 | 2024 | 89 | 6.490 |
Why?
|
| Hippocampus | 35 | 2024 | 816 | 5.730 |
Why?
|
| Stress, Psychological | 27 | 2018 | 555 | 5.700 |
Why?
|
| Rats, Wistar | 63 | 2023 | 359 | 5.660 |
Why?
|
| Dentate Gyrus | 14 | 2019 | 52 | 5.030 |
Why?
|
| CA1 Region, Hippocampal | 14 | 2019 | 72 | 4.440 |
Why?
|
| Memory Disorders | 23 | 2015 | 235 | 4.410 |
Why?
|
| Physical Conditioning, Animal | 11 | 2018 | 92 | 4.380 |
Why?
|
| Rats | 95 | 2023 | 3665 | 3.960 |
Why?
|
| Sleep Deprivation | 11 | 2016 | 49 | 3.880 |
Why?
|
| Alzheimer Disease | 15 | 2017 | 763 | 3.740 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 29 | 2023 | 168 | 3.190 |
Why?
|
| Amyloid beta-Peptides | 14 | 2019 | 206 | 3.130 |
Why?
|
| Brain-Derived Neurotrophic Factor | 23 | 2018 | 117 | 2.830 |
Why?
|
| Superior Cervical Ganglion | 11 | 2013 | 15 | 2.630 |
Why?
|
| Calcineurin | 24 | 2020 | 100 | 2.490 |
Why?
|
| Caffeine | 6 | 2016 | 69 | 2.460 |
Why?
|
| Neuronal Plasticity | 9 | 2024 | 274 | 2.150 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 12 | 2018 | 110 | 2.090 |
Why?
|
| Memory, Long-Term | 5 | 2018 | 42 | 2.070 |
Why?
|
| Synaptic Transmission | 32 | 2024 | 348 | 1.920 |
Why?
|
| Central Nervous System Stimulants | 5 | 2016 | 124 | 1.910 |
Why?
|
| Animals | 124 | 2024 | 33923 | 1.900 |
Why?
|
| Thyroxine | 5 | 2023 | 65 | 1.890 |
Why?
|
| Ganglia, Sympathetic | 14 | 2008 | 23 | 1.810 |
Why?
|
| Neuroprotective Agents | 4 | 2018 | 150 | 1.610 |
Why?
|
| Maze Learning | 19 | 2015 | 127 | 1.520 |
Why?
|
| Disease Models, Animal | 29 | 2017 | 4308 | 1.510 |
Why?
|
| Neuromuscular Junction | 9 | 2024 | 92 | 1.440 |
Why?
|
| Electric Stimulation | 30 | 2013 | 320 | 1.430 |
Why?
|
| Cognition Disorders | 6 | 2012 | 555 | 1.390 |
Why?
|
| Nicotinic Agonists | 6 | 2011 | 44 | 1.340 |
Why?
|
| Signal Transduction | 13 | 2020 | 4524 | 1.280 |
Why?
|
| Aspartic Acid Endopeptidases | 4 | 2017 | 39 | 1.140 |
Why?
|
| Sleep, REM | 3 | 2016 | 24 | 1.130 |
Why?
|
| Peptide Fragments | 7 | 2017 | 745 | 1.120 |
Why?
|
| Amyloid Precursor Protein Secretases | 4 | 2017 | 62 | 1.120 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 10 | 2007 | 118 | 1.110 |
Why?
|
| Phosphorylation | 17 | 2015 | 1617 | 1.090 |
Why?
|
| Male | 92 | 2020 | 59866 | 1.050 |
Why?
|
| Memory, Short-Term | 7 | 2014 | 139 | 1.000 |
Why?
|
| Action Potentials | 25 | 2013 | 499 | 0.990 |
Why?
|
| Memory | 6 | 2014 | 358 | 0.990 |
Why?
|
| Miniature Postsynaptic Potentials | 1 | 2024 | 2 | 0.980 |
Why?
|
| Ganglionic Stimulants | 4 | 2010 | 11 | 0.950 |
Why?
|
| Calmodulin | 11 | 2023 | 228 | 0.910 |
Why?
|
| Hypertension | 9 | 2013 | 1275 | 0.870 |
Why?
|
| Excitatory Postsynaptic Potentials | 11 | 2015 | 129 | 0.810 |
Why?
|
| Thyroidectomy | 10 | 2023 | 100 | 0.790 |
Why?
|
| Protein Kinase C | 11 | 2020 | 151 | 0.770 |
Why?
|
| In Vitro Techniques | 32 | 2011 | 969 | 0.760 |
Why?
|
| Down-Regulation | 8 | 2016 | 702 | 0.750 |
Why?
|
| Synapses | 6 | 2021 | 448 | 0.720 |
Why?
|
| Calcium | 15 | 2023 | 1097 | 0.700 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 4 | 8 | 2015 | 47 | 0.700 |
Why?
|
| Space Perception | 4 | 2010 | 62 | 0.690 |
Why?
|
| Chronic Disease | 11 | 2014 | 1168 | 0.680 |
Why?
|
| Veratridine | 5 | 2000 | 5 | 0.680 |
Why?
|
| Spatial Memory | 1 | 2020 | 37 | 0.670 |
Why?
|
| Rats, Sprague-Dawley | 21 | 2013 | 1217 | 0.670 |
Why?
|
| Long-Term Synaptic Depression | 3 | 2008 | 13 | 0.650 |
Why?
|
| Time Factors | 20 | 2018 | 6202 | 0.620 |
Why?
|
| Sodium Channels | 5 | 2000 | 109 | 0.620 |
Why?
|
| Blotting, Western | 10 | 2013 | 1106 | 0.610 |
Why?
|
| Behavior, Animal | 10 | 2013 | 477 | 0.590 |
Why?
|
| Analysis of Variance | 8 | 2013 | 1005 | 0.580 |
Why?
|
| Pyramidal Cells | 5 | 2000 | 168 | 0.580 |
Why?
|
| Autonomic Nervous System Diseases | 2 | 2008 | 42 | 0.560 |
Why?
|
| Oxidative Stress | 5 | 2017 | 804 | 0.550 |
Why?
|
| Receptors, Nicotinic | 4 | 2012 | 154 | 0.530 |
Why?
|
| Motor Endplate | 7 | 2024 | 15 | 0.530 |
Why?
|
| Learning | 6 | 2013 | 358 | 0.500 |
Why?
|
| Electrophysiology | 10 | 2008 | 269 | 0.500 |
Why?
|
| Neurons | 9 | 2012 | 1933 | 0.500 |
Why?
|
| Brain Diseases | 1 | 2018 | 298 | 0.500 |
Why?
|
| Brain | 5 | 2017 | 2961 | 0.480 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 2 | 2012 | 57 | 0.480 |
Why?
|
| Social Environment | 2 | 2014 | 119 | 0.480 |
Why?
|
| Motor Activity | 3 | 2014 | 508 | 0.460 |
Why?
|
| Serotonin | 5 | 2005 | 222 | 0.460 |
Why?
|
| Epilepsy | 6 | 1999 | 859 | 0.440 |
Why?
|
| Physical Exertion | 1 | 2013 | 80 | 0.430 |
Why?
|
| Receptors, Serotonin | 5 | 2002 | 42 | 0.430 |
Why?
|
| Random Allocation | 5 | 2018 | 417 | 0.430 |
Why?
|
| Ganglia | 3 | 2002 | 20 | 0.420 |
Why?
|
| Exercise Therapy | 1 | 2014 | 143 | 0.420 |
Why?
|
| Stress, Physiological | 4 | 2017 | 265 | 0.420 |
Why?
|
| Enzyme Inhibitors | 5 | 2008 | 582 | 0.420 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2013 | 139 | 0.400 |
Why?
|
| Valproic Acid | 5 | 2000 | 165 | 0.400 |
Why?
|
| Emetine | 5 | 2008 | 7 | 0.390 |
Why?
|
| Exercise | 1 | 2017 | 790 | 0.370 |
Why?
|
| Receptors, Serotonin, 5-HT3 | 6 | 2008 | 7 | 0.370 |
Why?
|
| Diet, High-Fat | 1 | 2012 | 207 | 0.370 |
Why?
|
| Blood Pressure | 5 | 2013 | 1317 | 0.360 |
Why?
|
| Aging | 3 | 2019 | 1175 | 0.350 |
Why?
|
| Nitric Oxide | 4 | 2008 | 439 | 0.340 |
Why?
|
| Adenosine | 3 | 1998 | 126 | 0.340 |
Why?
|
| Social Behavior | 3 | 2010 | 206 | 0.340 |
Why?
|
| Anxiety | 5 | 2013 | 952 | 0.330 |
Why?
|
| Serotonin Antagonists | 5 | 2008 | 24 | 0.330 |
Why?
|
| MAP Kinase Signaling System | 3 | 2009 | 320 | 0.330 |
Why?
|
| Exercise Test | 3 | 2017 | 248 | 0.320 |
Why?
|
| Serotonin Receptor Agonists | 3 | 1997 | 23 | 0.320 |
Why?
|
| Perforant Pathway | 2 | 2014 | 13 | 0.320 |
Why?
|
| Anticonvulsants | 3 | 2000 | 372 | 0.320 |
Why?
|
| Ganglionic Blockers | 8 | 1998 | 13 | 0.320 |
Why?
|
| Infusions, Intraventricular | 2 | 2018 | 12 | 0.310 |
Why?
|
| Nitric Oxide Synthase Type I | 4 | 2008 | 29 | 0.290 |
Why?
|
| Dietary Fats | 1 | 2009 | 288 | 0.290 |
Why?
|
| Imidazoles | 1 | 2008 | 200 | 0.290 |
Why?
|
| Nitroarginine | 3 | 2008 | 11 | 0.280 |
Why?
|
| Sulfonamides | 1 | 2008 | 258 | 0.270 |
Why?
|
| Diet | 2 | 2013 | 1112 | 0.270 |
Why?
|
| Heme Oxygenase (Decyclizing) | 4 | 2008 | 12 | 0.260 |
Why?
|
| Potassium Channels | 3 | 1993 | 158 | 0.260 |
Why?
|
| Gene Expression Regulation | 3 | 2013 | 2541 | 0.260 |
Why?
|
| Task Performance and Analysis | 2 | 2020 | 95 | 0.250 |
Why?
|
| Infusion Pumps, Implantable | 2 | 2018 | 40 | 0.250 |
Why?
|
| Membrane Potentials | 10 | 2000 | 304 | 0.250 |
Why?
|
| Dose-Response Relationship, Radiation | 4 | 2006 | 69 | 0.250 |
Why?
|
| Rats, Zucker | 4 | 2008 | 41 | 0.240 |
Why?
|
| Vertebrates | 1 | 2024 | 41 | 0.240 |
Why?
|
| Acetylcholine | 1 | 2024 | 83 | 0.240 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2021 | 147 | 0.230 |
Why?
|
| Patch-Clamp Techniques | 4 | 2011 | 277 | 0.230 |
Why?
|
| Cyclic AMP | 3 | 1998 | 247 | 0.220 |
Why?
|
| Vitis | 2 | 2013 | 14 | 0.220 |
Why?
|
| Anesthesia | 1 | 2006 | 209 | 0.220 |
Why?
|
| Propylthiouracil | 1 | 2023 | 9 | 0.210 |
Why?
|
| Depression | 1 | 2011 | 1216 | 0.210 |
Why?
|
| Nitric Oxide Synthase | 4 | 2008 | 186 | 0.210 |
Why?
|
| Convulsants | 2 | 2000 | 21 | 0.210 |
Why?
|
| Amygdala | 2 | 2011 | 80 | 0.200 |
Why?
|
| Cesium | 3 | 2008 | 13 | 0.200 |
Why?
|
| Drug Delivery Systems | 2 | 2013 | 181 | 0.190 |
Why?
|
| Chlorides | 3 | 2008 | 104 | 0.190 |
Why?
|
| Carbon Monoxide | 1 | 2001 | 27 | 0.190 |
Why?
|
| Carbamazepine | 1 | 2000 | 49 | 0.180 |
Why?
|
| Glutamates | 1 | 2021 | 69 | 0.180 |
Why?
|
| Electrophysiological Phenomena | 2 | 2011 | 65 | 0.180 |
Why?
|
| Ondansetron | 3 | 2008 | 9 | 0.180 |
Why?
|
| Bicuculline | 5 | 1999 | 21 | 0.180 |
Why?
|
| Biophysics | 2 | 2011 | 49 | 0.180 |
Why?
|
| Ion Transport | 1 | 2000 | 49 | 0.170 |
Why?
|
| Immunoblotting | 2 | 2014 | 312 | 0.160 |
Why?
|
| Receptors, Dopamine | 4 | 1987 | 40 | 0.160 |
Why?
|
| Cognition | 1 | 2024 | 734 | 0.160 |
Why?
|
| Obesity | 3 | 2008 | 2089 | 0.160 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 1999 | 59 | 0.160 |
Why?
|
| Purinergic P1 Receptor Agonists | 1 | 1998 | 5 | 0.160 |
Why?
|
| Body Weight | 3 | 2012 | 966 | 0.160 |
Why?
|
| Infusion Pumps | 1 | 2018 | 33 | 0.160 |
Why?
|
| Up-Regulation | 2 | 2013 | 874 | 0.150 |
Why?
|
| Adenylyl Cyclases | 3 | 2007 | 75 | 0.150 |
Why?
|
| Neurotransmitter Agents | 4 | 1993 | 145 | 0.150 |
Why?
|
| Serotonin 5-HT3 Receptor Antagonists | 2 | 2008 | 2 | 0.140 |
Why?
|
| Neuroprotection | 1 | 2017 | 19 | 0.140 |
Why?
|
| Humans | 8 | 2024 | 122853 | 0.140 |
Why?
|
| Rana pipiens | 9 | 1993 | 37 | 0.140 |
Why?
|
| Rats, Inbred Strains | 8 | 1992 | 229 | 0.140 |
Why?
|
| Benzazepines | 4 | 1987 | 64 | 0.140 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 2007 | 100 | 0.130 |
Why?
|
| Corticosterone | 4 | 2014 | 61 | 0.130 |
Why?
|
| Hydrazines | 2 | 1986 | 28 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 2 | 2014 | 1116 | 0.130 |
Why?
|
| Brain Waves | 1 | 2015 | 46 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2006 | 94 | 0.120 |
Why?
|
| Calcium Signaling | 2 | 2010 | 241 | 0.120 |
Why?
|
| Running | 1 | 2014 | 36 | 0.120 |
Why?
|
| Drug Administration Schedule | 2 | 2007 | 731 | 0.120 |
Why?
|
| 4-Aminopyridine | 4 | 2008 | 32 | 0.120 |
Why?
|
| Electrodes | 1 | 2014 | 97 | 0.120 |
Why?
|
| Ganglia, Spinal | 4 | 1987 | 73 | 0.120 |
Why?
|
| Indoles | 2 | 2008 | 182 | 0.120 |
Why?
|
| Protein Kinases | 2 | 2006 | 330 | 0.110 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2013 | 37 | 0.110 |
Why?
|
| Catheters, Indwelling | 1 | 2014 | 156 | 0.110 |
Why?
|
| GABA Antagonists | 3 | 1999 | 20 | 0.110 |
Why?
|
| Lactoylglutathione Lyase | 4 | 2013 | 12 | 0.110 |
Why?
|
| Dihydro-beta-Erythroidine | 1 | 2012 | 4 | 0.110 |
Why?
|
| Nicotinic Antagonists | 1 | 2012 | 9 | 0.110 |
Why?
|
| Aconitine | 1 | 2012 | 9 | 0.110 |
Why?
|
| 8-Hydroxy-2-(di-n-propylamino)tetralin | 3 | 1997 | 5 | 0.100 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 355 | 0.100 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 1992 | 6 | 0.100 |
Why?
|
| Plant Extracts | 1 | 2013 | 118 | 0.100 |
Why?
|
| Presynaptic Terminals | 2 | 2004 | 76 | 0.100 |
Why?
|
| Rabbits | 4 | 2008 | 717 | 0.100 |
Why?
|
| Adenosine Triphosphate | 1 | 1993 | 288 | 0.100 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 1993 | 167 | 0.100 |
Why?
|
| Autonomic Fibers, Preganglionic | 3 | 2008 | 5 | 0.100 |
Why?
|
| Glutathione | 1 | 2013 | 198 | 0.100 |
Why?
|
| Rubidium | 1 | 1991 | 5 | 0.100 |
Why?
|
| Strontium | 1 | 1991 | 3 | 0.100 |
Why?
|
| Fruit | 1 | 2013 | 216 | 0.100 |
Why?
|
| Second Messenger Systems | 1 | 1991 | 12 | 0.100 |
Why?
|
| Barium | 1 | 1991 | 18 | 0.100 |
Why?
|
| Predatory Behavior | 1 | 2011 | 9 | 0.100 |
Why?
|
| Dogs | 4 | 2008 | 770 | 0.090 |
Why?
|
| Amnesia | 1 | 2011 | 20 | 0.090 |
Why?
|
| Estrogens | 1 | 2013 | 507 | 0.090 |
Why?
|
| Neuropsychological Tests | 2 | 2014 | 923 | 0.090 |
Why?
|
| Depressive Disorder | 1 | 2014 | 450 | 0.090 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2011 | 121 | 0.090 |
Why?
|
| Amyloid | 1 | 2010 | 65 | 0.090 |
Why?
|
| Temperature | 2 | 2008 | 304 | 0.090 |
Why?
|
| Histamine H2 Antagonists | 1 | 1990 | 49 | 0.080 |
Why?
|
| Prefrontal Cortex | 1 | 2011 | 180 | 0.080 |
Why?
|
| Renal Artery | 2 | 1987 | 73 | 0.080 |
Why?
|
| Risk | 1 | 2011 | 744 | 0.080 |
Why?
|
| Guanylate Cyclase | 1 | 2008 | 37 | 0.080 |
Why?
|
| Evoked Potentials | 3 | 1996 | 140 | 0.080 |
Why?
|
| Tropanes | 1 | 2008 | 2 | 0.080 |
Why?
|
| Aminoquinolines | 1 | 2008 | 35 | 0.080 |
Why?
|
| Glutathione Reductase | 3 | 2013 | 13 | 0.080 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2008 | 26 | 0.080 |
Why?
|
| Guinea Pigs | 1 | 2008 | 169 | 0.080 |
Why?
|
| Cold Temperature | 1 | 2008 | 81 | 0.080 |
Why?
|
| Potassium Channel Blockers | 1 | 2008 | 83 | 0.080 |
Why?
|
| Vasoconstriction | 2 | 2005 | 104 | 0.080 |
Why?
|
| Anxiety Disorders | 1 | 2014 | 676 | 0.080 |
Why?
|
| Administration, Oral | 1 | 2010 | 669 | 0.070 |
Why?
|
| Phosphotransferases | 1 | 2007 | 43 | 0.070 |
Why?
|
| Nitrendipine | 1 | 1987 | 1 | 0.070 |
Why?
|
| Treatment Outcome | 3 | 2014 | 12070 | 0.070 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2008 | 115 | 0.070 |
Why?
|
| Verapamil | 1 | 1987 | 52 | 0.070 |
Why?
|
| Thyroid Hormones | 1 | 2007 | 66 | 0.070 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2007 | 23 | 0.070 |
Why?
|
| Fluoxetine | 2 | 1997 | 43 | 0.070 |
Why?
|
| Calcium Channel Blockers | 1 | 1987 | 113 | 0.070 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2014 | 621 | 0.070 |
Why?
|
| CREB-Binding Protein | 1 | 2007 | 63 | 0.070 |
Why?
|
| Spatial Behavior | 1 | 2006 | 15 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2007 | 83 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2001 | 1689 | 0.070 |
Why?
|
| Weight Gain | 1 | 2009 | 383 | 0.070 |
Why?
|
| Hemicholinium 3 | 1 | 1986 | 3 | 0.070 |
Why?
|
| Phthalic Acids | 1 | 1986 | 7 | 0.070 |
Why?
|
| Models, Neurological | 1 | 2007 | 204 | 0.070 |
Why?
|
| Dopamine | 3 | 1987 | 275 | 0.070 |
Why?
|
| Neurogranin | 1 | 2006 | 2 | 0.070 |
Why?
|
| Sympathetic Nervous System | 2 | 1985 | 62 | 0.070 |
Why?
|
| Magnesium | 3 | 1997 | 121 | 0.060 |
Why?
|
| Aggression | 1 | 2008 | 226 | 0.060 |
Why?
|
| Psychology | 1 | 2006 | 57 | 0.060 |
Why?
|
| Cell Fractionation | 1 | 2005 | 38 | 0.060 |
Why?
|
| Ion Channel Gating | 2 | 2000 | 123 | 0.060 |
Why?
|
| Tetrodotoxin | 2 | 1996 | 50 | 0.060 |
Why?
|
| Organophosphorus Compounds | 1 | 1985 | 23 | 0.060 |
Why?
|
| Blood Vessels | 1 | 2005 | 104 | 0.060 |
Why?
|
| Organ Culture Techniques | 1 | 2005 | 155 | 0.060 |
Why?
|
| Escape Reaction | 1 | 2004 | 15 | 0.060 |
Why?
|
| Cardiovascular System | 1 | 1985 | 99 | 0.060 |
Why?
|
| Hexamethonium Compounds | 4 | 1990 | 6 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2004 | 111 | 0.050 |
Why?
|
| Adaptation, Physiological | 1 | 2005 | 265 | 0.050 |
Why?
|
| Subcellular Fractions | 1 | 2003 | 98 | 0.050 |
Why?
|
| Superoxide Dismutase | 2 | 2013 | 141 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 207 | 0.050 |
Why?
|
| Methylmercury Compounds | 1 | 1982 | 3 | 0.050 |
Why?
|
| Cytosol | 1 | 2003 | 160 | 0.050 |
Why?
|
| Dinoprost | 2 | 2013 | 28 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 1302 | 0.050 |
Why?
|
| Thinness | 1 | 2003 | 68 | 0.050 |
Why?
|
| Neural Pathways | 1 | 2004 | 263 | 0.050 |
Why?
|
| Brain Chemistry | 2 | 2013 | 122 | 0.050 |
Why?
|
| Rats, Inbred WKY | 1 | 2001 | 54 | 0.050 |
Why?
|
| Rats, Inbred SHR | 1 | 2001 | 64 | 0.050 |
Why?
|
| Models, Biological | 1 | 2007 | 1439 | 0.050 |
Why?
|
| Protoporphyrins | 1 | 2001 | 8 | 0.050 |
Why?
|
| Oxyhemoglobins | 1 | 2001 | 22 | 0.050 |
Why?
|
| Species Specificity | 1 | 2001 | 552 | 0.050 |
Why?
|
| Electric Conductivity | 2 | 1995 | 89 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2003 | 460 | 0.050 |
Why?
|
| (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride | 1 | 1980 | 1 | 0.040 |
Why?
|
| Parasympathomimetics | 1 | 1980 | 7 | 0.040 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 1980 | 27 | 0.040 |
Why?
|
| Ethosuximide | 1 | 2000 | 9 | 0.040 |
Why?
|
| Phenytoin | 1 | 2000 | 64 | 0.040 |
Why?
|
| Fenoldopam | 4 | 1987 | 11 | 0.040 |
Why?
|
| Muscles | 2 | 1993 | 289 | 0.040 |
Why?
|
| Age Factors | 1 | 2006 | 2796 | 0.040 |
Why?
|
| Tetany | 1 | 1998 | 2 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2005 | 2833 | 0.040 |
Why?
|
| Nitroprusside | 1 | 1999 | 46 | 0.040 |
Why?
|
| Sodium | 1 | 2000 | 290 | 0.040 |
Why?
|
| Adenylyl Cyclase Inhibitors | 1 | 1998 | 9 | 0.040 |
Why?
|
| Streptomycin | 1 | 1978 | 18 | 0.040 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 1 | 1998 | 22 | 0.040 |
Why?
|
| Vasopressins | 1 | 1998 | 43 | 0.040 |
Why?
|
| Muscle Contraction | 4 | 1986 | 186 | 0.040 |
Why?
|
| Phenobarbital | 1 | 1998 | 36 | 0.040 |
Why?
|
| Sulpiride | 3 | 1987 | 5 | 0.040 |
Why?
|
| Barium Compounds | 1 | 1997 | 6 | 0.040 |
Why?
|
| Biological Transport | 1 | 1998 | 347 | 0.040 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 1998 | 52 | 0.040 |
Why?
|
| Aminopyridines | 3 | 1989 | 53 | 0.040 |
Why?
|
| Adrenergic beta-Agonists | 1 | 1998 | 93 | 0.040 |
Why?
|
| Chlorisondamine | 2 | 1974 | 6 | 0.040 |
Why?
|
| Amphetamines | 1 | 1996 | 10 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 1998 | 621 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1996 | 151 | 0.030 |
Why?
|
| Risk Factors | 1 | 2010 | 9928 | 0.030 |
Why?
|
| Spiders | 1 | 1974 | 6 | 0.030 |
Why?
|
| Tissue Extracts | 1 | 1974 | 13 | 0.030 |
Why?
|
| Exocrine Glands | 1 | 1974 | 8 | 0.030 |
Why?
|
| Venoms | 1 | 1974 | 20 | 0.030 |
Why?
|
| Tetraethylammonium Compounds | 2 | 1989 | 6 | 0.030 |
Why?
|
| Guanidines | 2 | 1989 | 25 | 0.030 |
Why?
|
| Anhedonia | 1 | 2014 | 30 | 0.030 |
Why?
|
| Powders | 1 | 2013 | 25 | 0.030 |
Why?
|
| Deoxyguanosine | 1 | 2013 | 13 | 0.030 |
Why?
|
| Cromakalim | 1 | 1993 | 2 | 0.030 |
Why?
|
| Food, Preserved | 1 | 2013 | 2 | 0.030 |
Why?
|
| Parasympatholytics | 1 | 1993 | 7 | 0.030 |
Why?
|
| Diazoxide | 1 | 1993 | 8 | 0.030 |
Why?
|
| Freeze Drying | 1 | 2013 | 14 | 0.030 |
Why?
|
| Benzopyrans | 1 | 1993 | 19 | 0.030 |
Why?
|
| Glyburide | 1 | 1993 | 22 | 0.030 |
Why?
|
| Polyphenols | 1 | 2013 | 19 | 0.030 |
Why?
|
| Receptors, GABA | 1 | 1993 | 14 | 0.030 |
Why?
|
| Buthionine Sulfoximine | 1 | 2013 | 28 | 0.030 |
Why?
|
| Central Nervous System Agents | 1 | 1993 | 15 | 0.030 |
Why?
|
| Ovariectomy | 1 | 2013 | 182 | 0.030 |
Why?
|
| Receptors, Cholinergic | 3 | 1982 | 84 | 0.030 |
Why?
|
| Atropine | 3 | 1980 | 30 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 144 | 0.030 |
Why?
|
| Meperidine | 1 | 1992 | 9 | 0.030 |
Why?
|
| Naloxone | 1 | 1992 | 46 | 0.020 |
Why?
|
| Morphine | 1 | 1992 | 87 | 0.020 |
Why?
|
| Pyrroles | 1 | 1993 | 177 | 0.020 |
Why?
|
| Ouabain | 2 | 1989 | 27 | 0.020 |
Why?
|
| Darkness | 1 | 2011 | 29 | 0.020 |
Why?
|
| Methadone | 1 | 1992 | 124 | 0.020 |
Why?
|
| Female | 7 | 2013 | 65278 | 0.020 |
Why?
|
| Light | 1 | 2011 | 175 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 1989 | 425 | 0.020 |
Why?
|
| Isoflurophate | 1 | 1990 | 1 | 0.020 |
Why?
|
| Cimetidine | 1 | 1990 | 14 | 0.020 |
Why?
|
| Ranitidine | 1 | 1990 | 30 | 0.020 |
Why?
|
| Dimethylphenylpiperazinium Iodide | 3 | 1981 | 3 | 0.020 |
Why?
|
| Ion Channels | 2 | 1982 | 187 | 0.020 |
Why?
|
| Potassium | 2 | 1989 | 279 | 0.020 |
Why?
|
| Ergolines | 2 | 1986 | 7 | 0.020 |
Why?
|
| Quinpirole | 2 | 1986 | 6 | 0.020 |
Why?
|
| Receptors, Dopamine D2 | 2 | 1986 | 38 | 0.020 |
Why?
|
| Tetraphenylborate | 1 | 1989 | 1 | 0.020 |
Why?
|
| 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid | 1 | 1989 | 3 | 0.020 |
Why?
|
| Anura | 2 | 1980 | 13 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2013 | 462 | 0.020 |
Why?
|
| Guanidine | 1 | 1989 | 10 | 0.020 |
Why?
|
| Manganese | 1 | 1989 | 46 | 0.020 |
Why?
|
| Receptors, Dopamine D1 | 2 | 1986 | 85 | 0.020 |
Why?
|
| Antioxidants | 1 | 2011 | 341 | 0.020 |
Why?
|
| Gene Expression | 1 | 2013 | 1592 | 0.020 |
Why?
|
| Ethanol | 1 | 1989 | 163 | 0.020 |
Why?
|
| Felodipine | 1 | 1987 | 1 | 0.020 |
Why?
|
| Autonomic Nervous System | 1 | 1987 | 45 | 0.020 |
Why?
|
| Chemistry | 1 | 1986 | 59 | 0.020 |
Why?
|
| Chemical Phenomena | 1 | 1986 | 84 | 0.020 |
Why?
|
| Neostigmine | 1 | 1986 | 6 | 0.020 |
Why?
|
| Acetylcholinesterase | 1 | 1986 | 20 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 1996 | 3083 | 0.020 |
Why?
|
| Stellate Ganglion | 1 | 1986 | 9 | 0.020 |
Why?
|
| Microbial Collagenase | 1 | 1986 | 12 | 0.020 |
Why?
|
| Solubility | 1 | 1986 | 132 | 0.020 |
Why?
|
| Artemia | 1 | 1985 | 3 | 0.020 |
Why?
|
| Lethal Dose 50 | 1 | 1985 | 17 | 0.020 |
Why?
|
| Hindlimb | 1 | 1985 | 75 | 0.020 |
Why?
|
| Cholinesterase Inhibitors | 1 | 1986 | 90 | 0.020 |
Why?
|
| 2-Chloroadenosine | 1 | 1984 | 6 | 0.020 |
Why?
|
| Neuromuscular Depolarizing Agents | 1 | 1984 | 5 | 0.020 |
Why?
|
| Theophylline | 1 | 1984 | 29 | 0.020 |
Why?
|
| Dipyridamole | 1 | 1984 | 29 | 0.020 |
Why?
|
| Depression, Chemical | 1 | 1984 | 43 | 0.010 |
Why?
|
| Vascular Resistance | 1 | 1985 | 189 | 0.010 |
Why?
|
| Nictitating Membrane | 2 | 1974 | 2 | 0.010 |
Why?
|
| Physostigmine | 2 | 1974 | 9 | 0.010 |
Why?
|
| Mecamylamine | 2 | 1974 | 10 | 0.010 |
Why?
|
| Cats | 2 | 1974 | 116 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1985 | 567 | 0.010 |
Why?
|
| Glycolates | 1 | 1982 | 12 | 0.010 |
Why?
|
| Pyrrolidines | 1 | 1982 | 36 | 0.010 |
Why?
|
| Neural Conduction | 1 | 1982 | 92 | 0.010 |
Why?
|
| Cyclic GMP | 1 | 1981 | 92 | 0.010 |
Why?
|
| Piperidines | 1 | 1982 | 196 | 0.010 |
Why?
|
| Norepinephrine | 2 | 1979 | 175 | 0.010 |
Why?
|
| Catecholamines | 1 | 1979 | 58 | 0.010 |
Why?
|
| Ketamine | 1 | 1982 | 209 | 0.010 |
Why?
|
| Nerve Endings | 1 | 1978 | 8 | 0.010 |
Why?
|
| Ganglia, Autonomic | 1 | 1978 | 6 | 0.010 |
Why?
|
| Epinephrine | 1 | 1977 | 174 | 0.010 |
Why?
|
| Methacholine Compounds | 1 | 1974 | 2 | 0.010 |
Why?
|
| Receptors, Adrenergic | 1 | 1974 | 29 | 0.010 |
Why?
|
| Autonomic Fibers, Postganglionic | 1 | 1973 | 1 | 0.010 |
Why?
|
| Isoproterenol | 2 | 1987 | 105 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1973 | 240 | 0.010 |
Why?
|
| Propranolol | 1 | 1987 | 128 | 0.000 |
Why?
|
| Phencyclidine | 1 | 1982 | 6 | 0.000 |
Why?
|
| Electric Organ | 1 | 1982 | 15 | 0.000 |
Why?
|
| Torpedo | 1 | 1982 | 37 | 0.000 |
Why?
|
| Bethanechol | 1 | 1981 | 1 | 0.000 |
Why?
|
| Bethanechol Compounds | 1 | 1981 | 2 | 0.000 |
Why?
|
| Drug Combinations | 1 | 1982 | 267 | 0.000 |
Why?
|
| Practolol | 1 | 1979 | 1 | 0.000 |
Why?
|
| Phentolamine | 1 | 1979 | 20 | 0.000 |
Why?
|
| Peptides | 1 | 1981 | 799 | 0.000 |
Why?
|